Intersect ENT (XENT) BidaskScore is upgraded to Held

Intersect ENT, Inc.

The BidaskScore of Intersect ENT Inc XENTXENT shows that the shares of the company are now XENTStrongly Bought Held by investors.

The BidaskScore of the PharmaceuticalsPharmaceuticals shows that the sector is PharmaceuticalsStrongly Bought Strongly Sold since October 1.

Here are the BidAskScore of other related companies in the Pharmaceuticals sector:

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Intersect ENT, Inc.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.